BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25953264)

  • 1. Expression profiling of cancer-related galectins in acute myeloid leukemia.
    El Leithy AA; Helwa R; Assem MM; Hassan NH
    Tumour Biol; 2015 Sep; 36(10):7929-39. PubMed ID: 25953264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
    Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
    Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression profiles of the galectin gene family in colorectal adenocarcinomas.
    Gopalan V; Saremi N; Sullivan E; Kabir S; Lu CT; Salajegheh A; Leung M; Smith RA; Lam AK
    Hum Pathol; 2016 Jul; 53():105-13. PubMed ID: 27001434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
    Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
    Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.
    Sun SM; Rockova V; Bullinger L; Dijkstra MK; Döhner H; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2013 Jan; 27(1):100-6. PubMed ID: 22692398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K
    Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
    Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
    Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
    Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
    Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
    Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
    Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression analysis of LATS2 gene in de novo AML patients.
    Gholami M; Mirfakhraie R; Movafagh A; Jalaeekhoo H; Kalahroodi R; Zare-Abdollahi D; Zare-Karizi S
    Med Oncol; 2014 May; 31(5):961. PubMed ID: 24743869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia.
    Qian J; Lin J; Qian W; Ma JC; Qian SX; Li Y; Yang J; Li JY; Wang CZ; Chai HY; Chen XX; Deng ZQ
    Leuk Res; 2013 Jul; 37(7):765-8. PubMed ID: 23582927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
    Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
    Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
    Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
    Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of transcription factor 4 (TCF4) is an independent adverse prognostic factor in acute myeloid leukemia that could guide treatment decisions.
    in 't Hout FE; van der Reijden BA; Monteferrario D; Jansen JH; Huls G
    Haematologica; 2014 Dec; 99(12):e257-9. PubMed ID: 25150259
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of miR-96 in patients with acute myeloid leukemia.
    Zhao J; Lu Q; Zhu J; Fu J; Chen YX
    Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-1 Overexpression as an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia.
    Pashaiefar H; Yaghmaie M; Tavakkoly-Bazzaz J; Ghaffari SH; Alimoghaddam K; Momeny M; Izadi P; Izadifard M; Kasaeian A; Ghavamzadeh A
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):343-349. PubMed ID: 29812960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFATc1 as a therapeutic target in FLT3-ITD-positive AML.
    Metzelder SK; Michel C; von Bonin M; Rehberger M; Hessmann E; Inselmann S; Solovey M; Wang Y; Sohlbach K; Brendel C; Stiewe T; Charles J; Ten Haaf A; Ellenrieder V; Neubauer A; Gattenlöhner S; Bornhäuser M; Burchert A
    Leukemia; 2015 Jul; 29(7):1470-7. PubMed ID: 25976987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.